OpenURL Connection Search

Select item for more details and to access through your institution.

Beyond the horizon: Immune checkpoint inhibitors reshaping the landscape of urothelial cancer.
Published in:
Indian Journal of Urology, 2024, v. 40, n. 4, p. 283, doi. 10.4103/iju.iju_51_24
By:
- Patel, Ojas
Publication type:
Article
Multicentre phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in Japanese advanced melanoma patients: immune resistance remains one of the major efforts in melanoma research.
Published in:
British Journal of Dermatology, 2024, v. 191, n. 5, p. 654, doi. 10.1093/bjd/ljae279
By:
- Kleemann, Johannes;
- Schilling, Bastian
Publication type:
Article
Nivolumab Plus Ipilimumab vs Chemotherapy as First-Line Treatment for Microsatellite Instability-High/Mismatch Repair--Deficient Metastatic Colorectal Cancer: Expanded Efficacy Analysis From Checkmate 8HW.
Published in:
Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 313
By:
- Lenz, Heinz-Josef;
- Lonardi, Sara;
- Fernandez, Elena Elez;
- Van Cutsem, Eric;
- Jensen, Lars Henrik;
- Bennouna, Jaafar;
- Mendez, Guillermo Ariel;
- Schenker, Michael;
- de la Fouchardiere, Christelle;
- Miron, Maria Luisa Limon;
- Yoshino, Takayuki
Publication type:
Article
Adverse Event Management With Cabozantinib Plus Nivolumab in Advanced Renal Cell Carcinoma.
Published in:
Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 309
By:
- Seery, Virginia;
- Andresen, Diane;
- Martone, Brenda;
- Lee-Ramos, Steven;
- Hall, Tasha;
- Virdee, Kiran
Publication type:
Article
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 5, p. 659, doi. 10.1007/s00280-024-04697-x
By:
- Gandhi, Khushboo A.;
- Shirsat, Aditi;
- HJ, Sharat Kumar;
- Chavan, Ashish;
- Dicholkar, Parnika;
- Shah, Saniya;
- Menon, Nandini;
- Noronha, Vanita;
- Joshi, Amit;
- Prabhash, Kumar;
- Patil, Vijay;
- Gota, Vikram
Publication type:
Article
Case report: Conjunctival melanoma treated with relatlimab and nivolumab showing remarkable response.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1428152
By:
- Attrash, Mirona;
- Badran, Omar;
- Shapira, Yinon;
- Bar-Sela, Gil
Publication type:
Article
Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer.
Published in:
Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1016, doi. 10.1177/10781552231199048
By:
- Truong, Jennifer;
- Yeung, Shirley S.T.;
- Kletas, Victoria;
- de Lemos, Mario;
- Schaff, Kimberly;
- Nakashima, Lynne
Publication type:
Article
Klassische Chemotherapie, Immuntherapie oder adjuvante Strahlentherapie – Wie können wir die onkologischen Ergebnisse der radikalen Zystektomie verbessern?
Published in:
Die Urologie, 2024, v. 63, n. 10, p. 994, doi. 10.1007/s00120-024-02433-0
By:
- Paffenholz, Pia;
- Zschäbitz, Stefanie
Publication type:
Article
Preclinical comparison of prolgolimab, pembrolizumab and nivolumab.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72118-3
By:
- Aleksandr, Gordeev;
- Andrei, Vaal;
- Maria, Puchkova;
- Iana, Smirnova;
- Aleksandr, Doronin;
- Anna, Znobishcheva;
- Daria, Zhmudanova;
- Aleksei, Aleksandrov;
- Mikhail, Sukchev;
- Evgeny, Imyanitov;
- Valery, Solovyev;
- Pavel, Iakovlev
Publication type:
Article
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series.
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 4, p. 615, doi. 10.1007/s00280-024-04659-3
By:
- Masuda, Takashi;
- Funakoshi, Taro;
- Horimatsu, Takahiro;
- Yamamoto, Shinya;
- Matsubara, Takeshi;
- Masui, Sho;
- Nakagawa, Shunsaku;
- Ikemi, Yasuaki;
- Yanagita, Motoko;
- Muto, Manabu;
- Terada, Tomohiro;
- Yonezawa, Atsushi
Publication type:
Article
Residue-Specific Epitope Mapping of the PD-1/Nivolumab Interaction Using X-ray Footprinting Mass Spectrometry.
Published in:
Antibodies (2073-4468), 2024, v. 13, n. 3, p. 77, doi. 10.3390/antib13030077
By:
- Kristensen, Line G.;
- Gupta, Sayan;
- Chen, Yan;
- Petzold, Christopher J.;
- Ralston, Corie Y.
Publication type:
Article
Cost-effectiveness of nivolumab plus gemcitabine-cisplatin as first-line treatment for advanced urothelial carcinoma in China and the United States.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1426024
By:
- Guiyuan Xiang;
- Yueyue Huang;
- Lanlan Gan;
- Linning Wang;
- Yunqi Ding;
- Yuanlin Wu;
- Haiyan Xing;
- Yao Liu
Publication type:
Article
Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer.
Published in:
Cancers, 2024, v. 16, n. 18, p. 3127, doi. 10.3390/cancers16183127
By:
- Yamanaka, Yuta;
- Ota, Takayo;
- Masuoka, Yutaka;
- Takeyasu, Yuki;
- Nakamura, Satoaki;
- Terashima, Masaaki;
- Yoshioka, Hiroshige;
- Fukuoka, Masahiro;
- Kurata, Takayasu
Publication type:
Article
The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study.
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5560, doi. 10.3390/jcm13185560
By:
- Okuda-Hiwatashi, Saki;
- Amagai, Ryo;
- Fujimura, Taku;
- Kambayashi, Yumi;
- Watanabe-Takahashi, Manami;
- Yamazaki, Emi;
- Tamabuchi, Erika;
- Itabashi, Chisato;
- Hashimoto, Akira;
- Asano, Yoshihide
Publication type:
Article
Aortic rupture following acute aortitis in a patient with head and neck carcinoma treated with nivolumab: a rare but severe immune-related adverse event.
Published in:
European Archives of Oto-Rhino-Laryngology, 2024, v. 281, n. 4, p. 2037, doi. 10.1007/s00405-024-08495-2
By:
- Ohno, Yuki;
- Ueki, Yushi;
- Oshima, Shusuke;
- Omata, Jo;
- Yokoyama, Yusuke;
- Takahashi, Takeshi;
- Shodo, Ryusuke;
- Yamazaki, Keisuke;
- Horii, Arata
Publication type:
Article
Impact of lymphopenia on efficacy of nivolumab in head and neck cancer patients.
Published in:
European Archives of Oto-Rhino-Laryngology, 2023, v. 280, n. 5, p. 2453, doi. 10.1007/s00405-022-07800-1
By:
- Césaire, Mathieu;
- Rambeau, Audrey;
- Clatot, Florian;
- Johnson, Alisson;
- Heutte, Natacha;
- Thariat, Juliette
Publication type:
Article
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03741-2
By:
- Messina, Carlo;
- Catalano, Martina;
- Roviello, Giandomenico;
- Gandini, Annalice;
- Maruzzo, Marco;
- De Giorgi, Ugo;
- Pedrazzoli, Paolo;
- Sbrana, Andrea;
- Zucal, Paolo Andrea;
- Masini, Cristina;
- Naglieri, Emanuele;
- Procopio, Giuseppe;
- Milella, Michele;
- Catalano, Fabio;
- Fratino, Lucia;
- Pipitone, Stefania;
- Ricotta, Riccardo;
- Panni, Stefano;
- Mollica, Veronica;
- Soraru, Mariella
Publication type:
Article
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03697-3
By:
- Moser, Justin C.;
- Bhatia, Shailender;
- Amin, Asim;
- Pavlick, Anna C.;
- Betts, Keith A.;
- Du, Ella Xiaoyan;
- Poretta, Tayla;
- Shelley, Karishma;
- Srinivasan, Swetha;
- Sakkal, Leon Alan;
- Palaia, Jennell;
- Lobo, Maurice;
- Pe Benito, Melanie;
- Linton, Joshua A.;
- Chen, Yan;
- Xu, Churong;
- Yin, Lei;
- Sundar, Manasvi;
- Weber, Jeffrey
Publication type:
Article
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4
By:
- Matsumoto, Kinnosuke;
- Shiroyama, Takayuki;
- Tamiya, Motohiro;
- Minami, Toshiyuki;
- Kinehara, Yuhei;
- Tamiya, Akihiro;
- Suga, Yasuhiko;
- Kuge, Tomoki;
- Mori, Masahide;
- Suzuki, Hidekazu;
- Tobita, Satoshi;
- Ueno, Kiyonobu;
- Namba, Yoshinobu;
- Tetsumoto, Satoshi;
- Niki, Toshie;
- Morimura, Osamu;
- Osa, Akio;
- Nishino, Kazumi;
- Nagatomo, Izumi;
- Takeda, Yoshito
Publication type:
Article
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2649, doi. 10.1007/s00262-023-03449-9
By:
- Toulemonde, E.;
- Chevret, S.;
- Battistella, M.;
- Neidhardt, E. M.;
- Nardin, C.;
- Le Du, F.;
- Meyer, N.;
- Véron, M.;
- Gambotti, L.;
- Lamrani-Ghaouti, A.;
- Jamme, P.;
- Chaffaut, C.;
- De Pontville, M.;
- Saada-Bouzid, E.;
- Beylot-Barry, M.;
- Simon, C.;
- Jouary, T.;
- Marabelle, A.;
- Mortier, L.
Publication type:
Article
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2099, doi. 10.1007/s00262-023-03383-w
By:
- Feils, A. S.;
- Erbe, A. K.;
- Birstler, J.;
- Kim, K.;
- Hoch, U.;
- Currie, S. L.;
- Nguyen, T.;
- Yu, D.;
- Siefker-Radtke, A. O.;
- Tannir, N.;
- Tolaney, S. M.;
- Diab, A.;
- Sondel, P. M.
Publication type:
Article
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1903, doi. 10.1007/s00262-023-03367-w
By:
- Shiota, Masaki;
- Miyake, Hideaki;
- Takahashi, Masayuki;
- Oya, Mototsugu;
- Tsuchiya, Norihiko;
- Masumori, Naoya;
- Matsuyama, Hideyasu;
- Obara, Wataru;
- Shinohara, Nobuo;
- Fujimoto, Kiyohide;
- Nozawa, Masahiro;
- Ohba, Kojiro;
- Ohyama, Chikara;
- Hashine, Katsuyoshi;
- Akamatsu, Shusuke;
- Kamba, Tomomi;
- Mita, Koji;
- Gotoh, Momokazu;
- Tatarano, Shuichi;
- Fujisawa, Masato
Publication type:
Article
Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Published in:
2023
By:
- Weber, Jeffrey S.;
- Poretta, Tayla;
- Stwalley, Brian D.;
- Sakkal, Leon A.;
- Du, Ella X.;
- Wang, Travis;
- Chen, Yan;
- Wang, Yan;
- Betts, Keith A.;
- Shoushtari, Alexander N.
Publication type:
Correction Notice
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 4, p. 945, doi. 10.1007/s00262-022-03302-5
By:
- Weber, Jeffrey S.;
- Poretta, Tayla;
- Stwalley, Brian D.;
- Sakkal, Leon A.;
- Du, Ella X.;
- Wang, Travis;
- Chen, Yan;
- Wang, Yan;
- Betts, Keith A.;
- Shoushtari, Alexander N.
Publication type:
Article
Pancreatic involvement due to immune checkpoint inhibitors: a proposed classification.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 4, p. 895, doi. 10.1007/s00262-022-03295-1
By:
- Ashkar, Motaz;
- Chandra, Shruti;
- Vege, Santhi Swaroop;
- Takahashi, Hiroaki;
- Takahashi, Naoki;
- McWilliams, Robert R.
Publication type:
Article
The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab.
Published in:
Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01370-8
By:
- Yoshimura, Akihiro;
- Nagahara, Akira;
- Ishizuya, Yu;
- Yamamoto, Yoshiyuki;
- Hatano, Koji;
- Kawashima, Atsunari;
- Nakai, Yasutomo;
- Nakayama, Masashi;
- Nishimura, Kazuo;
- Nonomura, Norio;
- Kato, Taigo
Publication type:
Article
Aktualisierte S3-Leitlinie Nierenzellkarzinom.
Published in:
Die Urologie, 2024, v. 63, n. 5, p. 439, doi. 10.1007/s00120-024-02328-0
By:
- Doehn, C.;
- Bergmann, L.;
- Decker, J.;
- Gauler, T.;
- Grünwald, V.;
- Weikert, St.;
- Krege, S.
Publication type:
Article
A case report of severe pulmonary arterial hypertension after nivolumab, an IgG4 anti-PD1 monoclonal antibody.
Published in:
European Heart Journal Case Reports, 2024, v. 8, n. 5, p. 1, doi. 10.1093/ehjcr/ytae222
By:
- Lei, Yuanli;
- Wang, Weijia
Publication type:
Article
First-Line Nivolumab Combination Therapy Improves Survival in Patients with Advanced Esophageal Squamous-Cell Carcinoma: CheckMate-648.
Published in:
Oncology Practice Management, 2022, v. 12, n. 5, p. 30
Publication type:
Article
Nivolumab plus Ipilimumab Yields High Rate of pCR in the Neoadjuvant Setting for Patients with Resectable MSI/dMMR Oeso-Gastric Adenocarcinoma.
Published in:
Oncology Practice Management, 2022, v. 12, n. 5, p. 16
By:
- King, William
Publication type:
Article
Pilot Study Shows Clinical Benefit with Nivolumab in Pediatric Patients with Hypermutant Cancers.
Published in:
Oncology Practice Management, 2021, v. 11, n. 12, p. 30
By:
- Dawson, Charlie
Publication type:
Article
Neoadjuvant Nivolumab plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable NSCLC.
Published in:
Oncology Practice Management, 2021, v. 11, n. 9, p. 17
By:
- Stewart, Patricia
Publication type:
Article
Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma.
Published in:
Oncology Practice Management, 2021, v. 11, n. 10, p. 37
Publication type:
Article
Comparative severe dermatologic toxicities of immune checkpoint inhibitors in malignant melanoma: A systematic review and network meta‐analysis.
Published in:
Journal of Cosmetic Dermatology, 2024, v. 23, n. 4, p. 1165, doi. 10.1111/jocd.16105
By:
- Mao, Yun‐tao;
- Wang, Ying;
- Chen, Xiao‐Xiao;
- Liu, Cheng‐jiang;
- Bao, Qi
Publication type:
Article
Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations—Going beyond the body‐size effect.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 3, p. 476, doi. 10.1002/psp4.13098
By:
- Hu, Zheyi;
- Liu, Sihang;
- Zhao, Yue;
- Du, Shengnan;
- Hamuro, Lora;
- Shen, Jun;
- Roy, Amit;
- Zhu, Li
Publication type:
Article
Pediatric model‐based dose optimization using a pooled exposure–response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 1, p. 168, doi. 10.1002/psp4.13070
By:
- Du, Shengnan;
- Zhao, Yue;
- Hu, Zheyi;
- Liu, Sihang;
- Roy, Amit;
- Shen, Jun;
- Zhu, Li;
- Hamuro, Lora
Publication type:
Article
Regorafenib compared to nivolumab after sorafenib failure in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Published in:
Advances in Clinical & Experimental Medicine, 2023, v. 32, n. 8, p. 839, doi. 10.17219/acem/158488
By:
- Shuheng Yang;
- Yadong Zhou;
- Lei Zeng
Publication type:
Article
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63403-2
By:
- Yamashita, Shimpei;
- Hamamoto, Shuzo;
- Furukawa, Junya;
- Fujita, Kazutoshi;
- Takahashi, Masayuki;
- Miyake, Makito;
- Ito, Noriyuki;
- Iwamoto, Hideto;
- Kohjimoto, Yasuo;
- Hara, Isao
Publication type:
Article
Dynamic Collaborations for the Development of Immune Checkpoint Blockade Agents.
Published in:
Journal of Personalized Medicine, 2021, v. 11, n. 6, p. 460, doi. 10.3390/jpm11060460
By:
- Djurian, Arisa;
- Makino, Tomohiro;
- Lim, Yeongjoo;
- Sengoku, Shintaro;
- Kodama, Kota
Publication type:
Article
Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311).
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1116937
By:
- Chawla, Sant P.;
- Tellez, Walter Andree;
- Chomoyan, Hripsime;
- Valencia, Chrysler;
- Ahari, Amir;
- Omelchenko, Nadezhda;
- Makrievski, Stefan;
- Brigham, Don A.;
- Chua-Alcala, Victoria;
- Quon, Doris;
- Moradkhani, Ania;
- Gordon, Erlinda M.
Publication type:
Article
Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1167791
By:
- Reiter, Selina;
- Schroeder, Christopher;
- Broche, Julian;
- Sinnberg, Tobias;
- Bonzheim, Irina;
- Süsskind, Daniela;
- Flatz, Lukas;
- Forschner, Andrea
Publication type:
Article
Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma--a case report.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1143335
By:
- Cerbon, Danielle;
- Moya-Brown, Karen;
- Mihaylov, Ivaylo B.;
- Spieler, Benjamin
Publication type:
Article
Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1126536
By:
- Manato Ohsawa;
- Yoichi Hamai;
- Manabu Emi;
- Yuta Ibuki;
- Tomoaki Kurokawa;
- Toru Yoshikawa;
- Ryosuke Hirohata;
- Nao Kitasaki;
- Morihito Okada
Publication type:
Article
Treatment options for recurrent platinum-resistant ovarian cancer: A systematic review and Bayesian network meta-analysis based on RCTs.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1114484
By:
- Juan Li;
- Guorong Zou;
- Wei Wang;
- Chen Yin;
- Haowen Yan;
- Shengpeng Liu
Publication type:
Article
Comparative cardiotoxicity risk of pembrolizumab versus nivolumab in cancer patients undergoing immune checkpoint inhibitor therapy: A meta-analysis.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1080998
By:
- Lessomo, Fabrice Yves Ndjana;
- Zhiquan Wang;
- Mukuka, Chishimba
Publication type:
Article
Comparison of the efficacy and safety of third-line treatments for advanced gastric cancer: A systematic review and network meta-analysis.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1118820
By:
- Chan Zhang;
- Yaoxian Xiang;
- Jing Wang;
- Dong Yan
Publication type:
Article
Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.1044587
By:
- Tarhini, Ahmad A.;
- Hanayneh, Wissam B.;
- Powers, John J.;
- Segura, Carlos M. Moran;
- Conejo-Garcia, Jose R.;
- Lam, Cesar A.;
- Hakam, Ardeshir;
- Hoffman, Mitchel S.
Publication type:
Article
Immune-related keratitis is a rare complication associated with nivolumab treatment in a patient with advanced colorectal cancer: A case report.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1021713
By:
- Yuqi Su;
- Guoquan Li;
- Jiaxin Xu;
- Jiale Zheng;
- Jiapeng Jiao;
- Jianhui Zhang;
- Xiaokang Gu;
- Zhai Cai;
- Hongyu Luo;
- Zhou Li;
- Shuai Han
Publication type:
Article
Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.969569
By:
- Jwa Hoon Kim;
- Gi Hwan Kim;
- Yeon-Mi Ryu;
- Sang-Yeob Kim;
- Hyung-Don Kim;
- Shin Kyo Yoon;
- Yong Mee Cho;
- Jae Lyun Lee
Publication type:
Article
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.955501
By:
- Rebuzzi, Sara Elena;
- Signori, Alessio;
- Stellato, Marco;
- Santini, Daniele;
- Maruzzo, Marco;
- Giorgi, Ugo De;
- Pedrazzoli, Paolo;
- Galli, Luca;
- Zucali, Paolo Andrea;
- Fantinel, Emanuela;
- Carella, Claudia;
- Procopio, Giuseppe;
- Milella, Michele;
- Boccardo, Francesco;
- Fratino, Lucia;
- Sabbatini, Roberto;
- Ricotta, Riccardo;
- Panni, Stefano;
- Massari, Francesco;
- Sorarù, Mariella
Publication type:
Article

Found: 870